Press Release Archive
-
The “Amazing Nurses” Contest: Celebrating America’s CaregiversThe Johnson & Johnson Campaign for Nursing’s Future Sponsors National Contest, Honoring Nurses’ Dedication To The Profession
-
Ortho Clinical Diagnostics Launches Vitros® 4600 Chemistry System For Mid- To High-Volume LaboratoriesState-of-the-art system completes VITROS® x600 family of analyzers
-
Zytiga® Receives Positive Regulatory Recommendation In The European Union For Treatment Of Metastatic Castration Resistant Prostate Cancer
-
Telaprevir Receives Positive Opinion From The Committee For Medicinal Products For Human Use (Chmp) For The Treatment Of Genotype-1 Hepatitis C Virus (HCV)Expanding new treatment class for patients with HCV
-
FDA Issues Complete Response Letter to Janssen Biotech, Inc. for SIMPONI® Supplemental Biologic License Application
-
Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results
-
Janssen Therapeutics Teams Up With Celebrity Designer David Bromstad To Encourage HIV Testing“Know Yourself: Get HIV Tested” Initiative Aims to Increase Awareness of HIV Testing Across the U.S.
-
FDA Advisory Committee Recommends Approval Of Remicade® For Treatment Of Pediatric Ulcerative Colitis
-
People With Diabetes Endure Swim Across English Channel To Raise Money For JDRFUsing The Waterproof Animas® Vibe™ Insulin Pump And CGM System, People With Diabetes To Participate In Channel Swim Relay
-
Johnson & Johnson Reports 2011 Second-Quarter Results:Sales of $16.6 Billion Increased 8.3% Versus 2010 Second-Quarter; Second-Quarter EPS was $1.00Excluding Special Items, 2011 Second-Quarter EPS of $1.28 Increased 5.8%*